Εμβόλια Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women 31/12/2024 time to read 2 min read
Ογκολογία Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer 28/11/2024 time to read 2 min read
Ογκολογία Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study 10/10/2024 time to read 2 min read
Εμβόλια Evaluation of the attributable fraction and burden of HPV-related oropharyngeal cancers in Greece-the ORPHEAS study 09/10/2024 time to read 2 min read
Ογκολογία Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial 05/10/2024 time to read 3 min read
Ογκολογία Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial 06/04/2024 time to read 3 min read
Ογκολογία Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 01/03/2024 time to read 2 min read
Ογκολογία Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial 01/02/2024 time to read 3 min read
Εμβόλια A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study 21/01/2024 time to read 2 min read
Ογκολογία First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826 20/12/2023 time to read 2 min read
Εμβόλια Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer Authors: Miriam Reuschenbach et al. 06/10/2023 time to read 2 min read
Ογκολογία Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer 08/06/2023 time to read 2 min read